Kishimoto Takashi Kei
SEC CIK 1676930 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RNAC | Cartesian Therapeutics, Inc. | CSO | 251.8K | — | $51.8K | 9 | 2021-10-01 | 2023-05-30 |
Most active insiders at RNAC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | BARABE TIMOTHY C | Dir | $205.8K | — |
| 2 | Brunn Carsten | Pres, CEO, Dir | — | $162.1K |
| 3 | Davis Blaine | CFO | — | $72.2K |
| 4 | Miljkovic Milos | Chief Medical Off | — | $24.4K |
| 5 | Bot Adrian Ion | Dir | — | — |
| 6 | Seymour June Ann | CAO | — | — |
| 7 | English Emily | Chief Ops Off | — | — |
| 8 | Hoge Elizabeth | 10% | — | — |
| 9 | Singer Michael | Dir | — | — |
| 10 | Kalayoglu Murat | Dir, 10% | — | — |
Kishimoto Takashi Kei made no open-market trades at RNAC in the last 12 months.
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-06-01 | 2023-05-30+ | RNAC | Cartesian Therapeutics, Inc. | Kishimoto Takashi Kei | CSO | G - Gift | $0.00 | -139.0K | 251.8K | -36% | $0 |
| M | 2023-01-06 | 2023-01-04+ | RNAC | Cartesian Therapeutics, Inc. | Kishimoto Takashi Kei | CSO | S - Sale | $1.13 | -9,784 | 364.3K | -3% | -$11.1K |
| D | 2023-01-04 | 2023-01-02 | RNAC | Cartesian Therapeutics, Inc. | Kishimoto Takashi Kei | CSO | A - Grant | $0.00 | +100.0K | 374.1K | +36% | $0 |
| 2022-01-07 | 2022-01-05 | RNAC | Cartesian Therapeutics, Inc. | Kishimoto Takashi Kei | CSO | S - Sale | $3.09 | -3,416 | 268.4K | -1% | -$10.6K | |
| D | 2022-01-05 | 2022-01-03 | RNAC | Cartesian Therapeutics, Inc. | Kishimoto Takashi Kei | CSO | A - Grant | $0.00 | +72.0K | 271.8K | +36% | $0 |
| 2021-12-14 | 2021-12-10 | RNAC | Cartesian Therapeutics, Inc. | Kishimoto Takashi Kei | CSO | S - Sale | $2.99 | -4,370 | 199.8K | -2% | -$13.1K | |
| 2021-12-10 | 2021-12-08 | RNAC | Cartesian Therapeutics, Inc. | Kishimoto Takashi Kei | CSO | A - Grant | $0.00 | +13.8K | 204.1K | +7% | $0 | |
| 2021-10-15 | 2021-10-13 | RNAC | Cartesian Therapeutics, Inc. | Kishimoto Takashi Kei | CSO | S - Sale | $4.39 | -3,892 | 190.4K | -2% | -$17.1K | |
| 2021-10-05 | 2021-10-01 | RNAC | Cartesian Therapeutics, Inc. | Kishimoto Takashi Kei | CSO | A - Grant | $0.00 | +13.8K | 194.3K | +8% | $0 |
Purchase Sale Sale after option exercise All abbreviations